Harvard Bioscience Inc. and its subsidiary Harvard Apparatus Regenerative Technology have high profit potential, stemming from ground breaking technology and a buy out of the parent company.
At Harver Group´s annual awards dinner last weekend, Senior Analyst Mr. Martin Owen received the Company’s highest honor; The Lifetime Achievement Award.
Mr. Koji Masuto at Harver Group in Tokyo will insist that the Company continues to invest in Asian equity this week as the Japanese markets look strong on US job markets and seem to have escaped the correction period.
Harver Group is to sending a delegation including CFO Mr. Masaaki Hisashi and Director of Investments Ms. Anita Schultz to attend the Asian Finance Association (AsFA) Annual Conference next week.
Founding partners at Harver Group Mr. Koji Masuto and Mr. James Aiguo today announced Harver Group is to hold a public open day in Hong Kong upon the opening of its new office in early 2014.
Harver Group’s Senior Vice President of Mergers and Acquisitions Mr. Peter Williams, who will be managing the 2014 opening of Harver Group’s Hong Kong branch today made a public appeal for market analyst applications.
Japanese Equity researcher, Harver Group has today announced plans to make significant investments within the Japanese markets off the back of the weak Yen which has fallen to a 3 year low.
Japanese stock market research agency Harver Group today announced the appointment of Mr. Stephen Rogers as an Executive Director on the company’s Board of Directors.